Case of recalcitrant necrobiotic xanthogranuloma

Australasian Journal of Dermatology

Volumn 45, Issue 4, 2004, Pages 213-215

  Wells, Jillian ^a,c   Gillespie, Rod ^a   Zardawi, Ibrahim ^b  

^a ROYAL NEWCASTLE HOSPITAL   (Australia)

^b Mayne Health   (Australia)

^c SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

Author keywords

Chlorambucil; Cyclophosphamide; Melphalan; Monoclonal gammopathy of uncertain significance

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; MELPHALAN; PARAPROTEIN; PREDNISONE;

ADULT; ARM; ARTICLE; CASE REPORT; CLINICAL FEATURE; EYELID; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; NECROBIOTIC DISORDER; NECROBIOTIC XANTHOGRANULOMA; PHYSICAL EXAMINATION; THIGH; TREATMENT OUTCOME; XANTHOGRANULOMA;

ANTI-INFLAMMATORY AGENTS; DIAGNOSIS, DIFFERENTIAL; EYELIDS; FEMALE; GRANULOMA; HUMANS; MIDDLE AGED; NECROBIOTIC DISORDERS; XANTHOMATOSIS;

EID: 8444226363     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2004.00099.x     Document Type: Article

References (13)

1. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J. Am. Acad. Dermatol. 1980; 3: 257-70.
2. Caputo R. Cutaneous nonhistiocytoses X. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds). Fitzpatrick's Dermatology in General Medicine, Vol. 2, 6th edn. New York: McGraw-Hill, 2003; 1590-9.
3. Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch. Dermatol. 1992; 128: 94-100.
4. Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am. J. Ophthalmol. 2000; 129: 651-7.
5. Chandra S, Finklestein E, Gill D. Necrobiotic xanthogranuloma occurring within linear morphea. Australas. J. Dermatol. 2002; 43: 52-4.
6. Stork J, Kodetova D, Vosmik F, Krejca M. Necrobiotic xanthogranuloma presenting as a solitary tumor. Am. J. Dermatopathol. 2000; 22: 453-6.
7. Criado PR, Vasconcellos C, Pegas JR, Lopes LF, Ramos CF, Tebcherani AJ, Valente NY. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone. J. Dermatolog. Treat. 2002; 13: 87-9.
8. Kossard S, Chow E, Wilkinson B, Killingsworth M. Lipid and giant cell poor necrobiotic xanthogranuloma. J. Cutan. Pathol. 2000; 27: 374-8.
9. Machado S, Alves R, Lima M, Leal I, Massa A. Cutaneous necrobiotic xanthogranuloma - successfully treated with low dose chlorambucil. Eur. J. Dermatol. 2001; 11: 458-62.
10. Chave TA, Chowdhury MMU, Holt PJA. Recalcitrant necrobiotic xanthogranuloma responding to pulsed high-dose oral dexamethasone plus maintenance therapy with oral prednisolone. Br. J. Dermatol. 2001; 144: 158-61.
11. Venencie PY, Le Bras P, Toan ND, Tchernia G, Delfraissy JF. Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia. J. Am. Acad. Dermatol. 1995; 32: 666-7.
12. Finelli LG, Ratz JL. Plasmapheresis, a treatment modality for necrobiotic xanthogranuloma. J. Am. Acad. Dermatol. 1987; 17: 351-4.
13. Brigden ML. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance? Postgrad. Med. 1999; 106: 135-42.